WELL Health Technologies Corp. (TSE:WELL) Given Consensus Rating of “Buy” by Brokerages

WELL Health Technologies Corp. (TSE:WELL) has been given an average rating of “Buy” by the six analysts that are presently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is C$7.35.

WELL has been the topic of several research reports. Scotiabank cut their target price on WELL Health Technologies from C$7.00 to C$6.50 and set an “outperform” rating on the stock in a research note on Wednesday, February 4th. Canadian Imperial Bank of Commerce raised WELL Health Technologies from a “neutral” rating to an “outperform” rating in a research report on Wednesday, December 3rd.

WELL Health Technologies Stock Performance

WELL opened at C$4.35 on Friday. The company has a market capitalization of C$1.10 billion, a price-to-earnings ratio of -48.33, a P/E/G ratio of -1.93 and a beta of 0.85. The business’s 50-day moving average price is C$4.08 and its two-hundred day moving average price is C$4.42. WELL Health Technologies has a 1 year low of C$3.58 and a 1 year high of C$6.08. The company has a debt-to-equity ratio of 73.92, a current ratio of 0.92 and a quick ratio of 1.02.

WELL Health Technologies Company Profile

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments.